Trial Information

Summary: A study to evaluate the safety and efficacy of Xyrem® for the treatment of Fibromyalgia syndrome.

Male or female patients over 18 years who have been diagnosed with fibromyalgia to participate in a trial lasting up to 27 weeks with 12 visits. Treatment period is 14 weeks. Patients who complete this study may be eligible to enter long-term (9 1/2 months) open-label extension study.

A subject will be eligible for trial participation if he/she meets the following criteria:

• Subject is male or female 18 years of age or older.

A subject will be excluded from the trial if he/she meets any of the following criteria:

• Pending worker’s compensation litigation or other related pending litigation related to physical complaints
• Subjects on disability or pending disability evaluation for chronic pain and/or fibromyalgia.
• An occupation that requires variable shift work or routine night shifts

Call Center:
Patient interested in more information should be directed to the following website:
http://www.myfibrostudy.com/

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:38:01 AM